Pronóstico del mercado de bioproducción de América del Sur y Central hasta 2030 – Análisis regional – por producto (productos biológicos y biosimilares, vacunas, terapias celulares y genéticas, terapias con ácidos nucleicos y otros), aplicación (artritis reumatoide, trastornos hematológicos, cáncer, diabetes, enfermedades cardiovasculares, y otros), equipos (equipos ascendentes, equipos descendentes, biorreactores y consumibles y accesorios) y usuarios finales (compañías biofarmacéuticas, organizaciones de fabricación por contrato y otros)
La expiración de la patente de productos biológicos de gran éxito impulsa el mercado de bioproducción de América del Sur y Central
Los productos biológicos representan nuevas terapias prometedoras para enfermedades previamente incurables y están adquiriendo gran importancia en el mercado farmacéutico. Se espera que las patentes sobre productos biológicos originales expiren en los próximos años.
En la siguiente tabla se muestran las fechas estimadas de vencimiento de patentes y exclusividad de los productos biológicos más vendidos.
Biológicos
Fechas de caducidad
Avastin
enero de 2022
Cyramza
mayo de 2023
Adcetris
agosto de 2023
Abthrax
octubre de 2024
Gazyva/ Gazyvaro
noviembre 2024
Darzalex
mayo 2026
Ocrevus
abril 2027
Emgality
septiembre 2028
Hemlibra
febrero 2028
Llumetri
marzo 2028
Imfinzi
Septiembre 2028
Mylotarg
Abril 2028
Imfinzi
Septiembre 2028
Mylotarg
Abril 2028
Sylvant
Julio 2034
The La expiración de las patentes y otros derechos de propiedad intelectual de los productos biológicos originales crearán la necesidad de introducir nuevos biosimilares en el futuro. Como resultado, la competencia entre los actores del mercado aumentará en la industria en los próximos años. Por lo tanto, se espera que la expiración de las patentes de productos biológicos de gran éxito cree oportunidades lucrativas para el mercado de bioproducción durante el período previsto.
Visión general del mercado de bioproducción de América del Sur y Central
El mercado de bioproducción en América del Sur y Central está subsegmentado en Brasil, Argentina y el resto de América del Sur y Central. Es probable que los crecientes desarrollos en la industria médica y la mayor conciencia sobre la terapia celular en Brasil creen importantes oportunidades de crecimiento para el crecimiento del mercado. De manera similar, se espera que la creciente industria de la salud en Argentina ofrezca oportunidades de crecimiento para el mercado de bioproducción.
Según un artículo publicado en Biomaterials Research, en 2020, Brasil estaba entre los diez primeros países del mundo con mayor número de personas con diabetes, y actualmente ocupa el quinto lugar. Actualmente, Brasil es el quinto país del mundo con mayor prevalencia de diabetes mellitus (DM) en adultos. Según la Federación Internacional de Diabetes (FID), se estima un aumento del 54,7% de nuevos casos de diabetes para 2045.
Según GaBI, en 2022, la Agencia Brasileña de Regulación Sanitaria (Agência Nacional de Vigilância Sanitária, ANVISA ) aprobó 30 biosimilares dentro de las clases de productos de insulina, anticuerpos monoclonales, inhibidores del factor de necrosis tumoral (TNF), hormona de crecimiento humano, anticoagulantes y heparinas, y factor estimulante de colonias de granulocitos para su uso en Brasil. La ANVISA aprobó el biosimilar Admelog de Sanofi en Brasil para el tratamiento de la diabetes. Por lo tanto, los crecientes casos de diabetes y las crecientes aprobaciones de productos en Brasil están impulsando el mercado de la bioproducción.
Ingresos y pronóstico del mercado de bioproducción de América del Sur y Central hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de bioproducción de América del Sur y Central
Se clasifica el mercado de bioproducción de América del Sur y Central por producto, aplicación, equipo, usuario final y país.
Según el producto, el mercado de bioproducción de América del Sur y Central está segmentado en productos biológicos y biosimilares, vacunas, terapias celulares y genéticas, terapias con ácidos nucleicos y otros. El segmento de productos biológicos y biosimilares tuvo la mayor participación de mercado de bioproducción de América del Sur y Central en 2022.
En términos de aplicación, el mercado de bioproducción de América del Sur y Central está segmentado en artritis reumatoide, trastornos hematológicos, cáncer, diabetes, enfermedades cardiovasculares y otros. El segmento del cáncer tuvo la mayor participación de mercado de bioproducción en América del Sur y Central en 2022.
Por equipos, el mercado de bioproducción de América del Sur y Central se divide en equipos upstream, downstream, biorreactores y consumibles y accesorios. El segmento de consumibles y accesorios tuvo la mayor participación de mercado de bioproducción de América del Sur y Central en 2022.
En términos de usuario final, el mercado de bioproducción de América del Sur y Central se clasifica en empresas biofarmacéuticas, organizaciones de fabricación por contrato y otras. El segmento de empresas biofarmacéuticas tuvo la mayor participación de mercado de bioproducción de América del Sur y Central en 2022.
Por país, el mercado de bioproducción de América del Sur y Central está segmentado en Brasil, Argentina y el resto de América del Sur y Central. Brasil dominó la cuota de mercado de bioproducción de América del Sur y Central en 2022.
Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd y Bio-Rad Laboratories Inc. son algunas de las empresas líderes que operan en el mercado de bioproducción de América del Sur y Central.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - South & Central America Market Analysis
5.1 South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 South & Central America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 South & Central America: Bioproduction Market
10.1.1 South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
10.1.1.1 Brazil: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.2.1 Brazil: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.2 Brazil: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.2.3 Brazil: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.4 Brazil: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.3 Argentina: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.4.1 Argentina: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.2 Argentina: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.4.3 Argentina: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.4 Argentina: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.5 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.6 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Bioproduction Market Segmentation
Table 2. South & Central America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market
List of Figures
Figure 1. South & Central America Bioproduction Market Segmentation, By Country
Figure 2. South & Central America Bioproduction Market: Key Industry Dynamics
Figure 3. South & Central America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America: Bioproduction Market, By Key Country - Revenue (2022) (US$ Million)
Figure 28. South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
Figure 29. Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 31. Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.